Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 14
Submit an article Journal homepage
4,194
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis

Wouter J. Plattela University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsView further author information
,
Aurore Bergamascob YOLARX Consultants, Paris, FranceView further author information
,
Fabrizio Trinchesec Takeda Pharmaceuticals International AG, Zurich, SwitzerlandView further author information
,
François Gavinic Takeda Pharmaceuticals International AG, Zurich, SwitzerlandView further author information
,
Nawal Bent-Ennakhilc Takeda Pharmaceuticals International AG, Zurich, SwitzerlandView further author information
,
Athanasios Zomasc Takeda Pharmaceuticals International AG, Zurich, SwitzerlandView further author information
,
Genaro Castillond YOLARX Consultants, Montreal, CanadaView further author information
,
Teigna Arredondo-Bisonob YOLARX Consultants, Paris, FranceView further author information
,
Tiffany Cristarellad YOLARX Consultants, Montreal, CanadaORCID Iconhttps://orcid.org/0000-0002-9334-6611View further author information
ORCID Icon,
Yola Morided YOLARX Consultants, Montreal, Canada;e Faculty of Pharmacy, Université de Montréal, Montreal, Canada;f Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
&
Bastian von Tresckowg Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;h Cancer Center Cologne Essen – Partner Site Essen, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyCorrespondence[email protected]
View further author information
 show all
Pages 3320-3332 | Received 02 Feb 2021, Accepted 11 Jul 2021, Published online: 29 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.